Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$187.54 - $223.02 $187,540 - $223,020
1,000 New
1,000 $204,000
Q1 2022

May 10, 2022

SELL
$193.77 - $244.14 $237,949 - $299,803
-1,228 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$259.0 - $414.71 $868,945 - $1.39 Million
-3,355 Reduced 73.21%
1,228 $425,000
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $182,212 - $213,472
-750 Reduced 14.06%
4,583 $1.28 Million
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $443,932 - $668,228
-1,879 Reduced 26.05%
5,333 $1.31 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $12,708 - $14,674
48 Added 0.67%
7,212 $2.05 Million
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $66,734 - $88,377
-258 Reduced 3.48%
7,164 $1.92 Million
Q1 2020

Apr 20, 2020

BUY
$268.85 - $341.04 $130,392 - $165,404
485 Added 6.99%
7,422 $2.35 Million
Q4 2019

Jan 31, 2020

SELL
$220.06 - $304.07 $70,639 - $97,606
-321 Reduced 4.42%
6,937 $2.06 Million
Q3 2019

Oct 31, 2019

BUY
$217.44 - $243.88 $13,481 - $15,120
62 Added 0.86%
7,258 $1.69 Million
Q2 2019

Aug 07, 2019

BUY
$219.29 - $241.72 $37,498 - $41,334
171 Added 2.43%
7,196 $1.68 Million
Q1 2019

Apr 25, 2019

BUY
$216.71 - $338.96 $41,391 - $64,741
191 Added 2.79%
7,025 $1.66 Million
Q4 2018

Feb 01, 2019

BUY
$278.5 - $352.75 $43,167 - $54,676
155 Added 2.32%
6,834 $2.06 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $74,845 - $97,876
-255 Reduced 3.68%
6,679 $2.36 Million
Q2 2018

Jul 20, 2018

SELL
$257.52 - $306.91 $4,377 - $5,217
-17 Reduced 0.24%
6,934 $2.01 Million
Q1 2018

May 08, 2018

SELL
$260.13 - $367.91 $1,820 - $2,575
-7 Reduced 0.1%
6,951 $1.9 Million
Q4 2017

Feb 07, 2018

BUY
$307.64 - $344.58 $127,055 - $142,311
413 Added 6.31%
6,958 $2.22 Million
Q3 2017

Oct 19, 2017

BUY
$281.15 - $329.69 $1.84 Million - $2.16 Million
6,545
6,545 $2.05 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.